Dr. David Brownstein,  editor of Dr. David Brownstein’s Natural Way to Health newsletter, is a board-certified family physician and one of the nation’s foremost practitioners of holistic medicine. Dr. Brownstein has lectured internationally to physicians and others about his success with natural hormones and nutritional therapies in his practice. His books include Drugs That Don’t Work and Natural Therapies That Do!; Iodine: Why You Need It, Why You Can’t Live Without It; Salt Your Way To Health; The Miracle of Natural Hormones; Overcoming Arthritis, Overcoming Thyroid Disorders; The Guide to a Gluten-Free Diet; and The Guide to Healthy Eating. He is the medical director of the Center for Holistic Medicine in West Bloomfield, Mich., where he lives with his wife, Allison, and their teenage daughters, Hailey and Jessica.

Tags: PSA test | PSA screening | prostate cancer detection | USPSTF prostate screening guidelines | Dr. David Brownstein

PSA Test Flunks

Monday, 02 Jul 2012 10:01 AM


Question: Do you agree with the latest government health recommendations regarding PSA testing for prostate cancer?

Dr. Brownstein's Answer:

A headline in the May 22, 2012, issue of the Wall Street Journal read, “Blood Test From Prostate Cancer Test Gets a ‘D’ From Panel.” My only criticism of the article is that the grade should have been an “F.”

The article referred to the U.S. Preventive Services Task Force (USPSTF) Recommendation Statement, which was published in the Annals of Internal Medicine on the same date. The USPSTF recommended that men should not be screened for prostate cancer with the prostate specific antigen (PSA) blood test. They reported a “moderate or high certainty that the (PSA test) has no benefit or that harms outweigh the benefits.”

The task force reviewed clinical studies of PSA testing, and the best of the studies found only a miniscule benefit from PSA screening. The researchers wrote, “There is good evidence that PSA-based screening prevents only zero to one prostate cancer death for every 1,000 men screened. No studies show any benefit in overall death rates.”

Millions of men have been screened with PSA testing and many have been told to have expensive and dangerous therapies to treat prostate cancer found by the test.

However, men were not told that the vast majority of prostate cancers are slow growing, and that the harm from treatment can vastly outweigh the benefits. This study is an indictment of PSA testing. It should also function as a necessary slap in the face to conventional medicine’s approach to treating cancer.

The American Cancer Society should be studying how to prevent cancer. Instead, they focus on early diagnosis and treatment. Unfortunately, by the time most cancers are diagnosed, it is too late.

Truly preventative measures will revolve around eating a healthier diet, detoxification, and supplementing to correct nutritional and hormonal imbalances.


© HealthDay

   
1Like our page
2Share
Dr-Brownstein
The USPSTF gets it right about PSA screening: The harm from dangerous and expensive treatments prompted by it can vastly outweigh any benefits.
PSA test,PSA screening,prostate cancer detection,USPSTF prostate screening guidelines,Dr. David Brownstein
310
2012-01-02
Monday, 02 Jul 2012 10:01 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved